Login / Signup

A novel treatment strategy using indocyanine green for transarterial chemoembolization in BCLC stage C hepatocellular carcinoma.

Jie MeiShao-Hua LiQiao-Xuan WangXiao-Ping ZhongLiang-He LuAnna KanWei WeiRong-Ping Guo
Published in: Cancer medicine (2019)
The SBI is suitable and may provide survival benefits for TACE treatments in BCLC stage C HCC patients.
Keyphrases
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • combination therapy
  • liver metastases
  • patient reported